Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
30%(3 trials)

Phase Distribution

Ph phase_3
1
10%
Ph phase_2
3
30%
Ph phase_1
6
60%

Phase Distribution

6

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
6(60.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (60.0%)
Phase 23 (30.0%)
Phase 31 (10.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_2

A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00372112
completedphase_3

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

NCT01316900
completedphase_1

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

NCT00671216
completedphase_1

A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients

NCT00702910
completedphase_1

Phase I Study of GW642444M in Healthy Japanese Male Subjects

NCT00964249
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00372112Phase 2

A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT01316900Phase 3

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

Completed
NCT00671216Phase 1

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

Completed
NCT00702910Phase 1

A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients

Completed
NCT00964249Phase 1

Phase I Study of GW642444M in Healthy Japanese Male Subjects

Completed
NCT00711126Phase 1

A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection

Completed
NCT00783003Phase 1

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

Completed
NCT01299558Phase 1

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects

Completed
NCT01453296Phase 2

Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects

Completed
NCT00354874Phase 2

Investigation Of A New Medication (GW642444) In Asthmatic Patients

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10